Moura DS, Lopez-Marti JM, Tawbi HA, Keung E, Wani KM, Lazar AJ, Wang WL, Ingram DR, Meza-Zepeda LA, Myklebost O, Burgess MA, Mondaza-Hernandez JL, Hindi N, Martín-Broto J (2026) Validation of a seven-gene predictive SIGNature for the efficacy of Immuno-Oncology PD-1 inhibitors in Sarcoma patients (SIGNIOS). Clin Cancer Res doi: 10.1158/1078-0432.CCR-25-2580
Mensali N, Joaquina S, de Montlaur C, Casey NP, Nesset TO, Myhre MR, Myklebost O, McCormack E, Passetto A, Gunnes MW, Gelebart P, Inderberg EM, Wälchli S (2026) Pre-clinical validation of OSCAR-3 mRNA-based CAR T cells for targeting Osteosarcomas. Cytotherapy doi: https://doi.org/10.1016/j.jcyt.2026.102930
Giordano G, Tucciarello C, Gucciardo G, Russo N, Wesche J, Myklebost O, Meza-Zepeda LA, Merlini A, Cutrupi S, Sangiolo D, Isella C, Sapino A, Marchiò C, Grignani G, Pignochino Y (2026) The paracrine ephrin A4/BMP4 feed-forward loop sustains a tumor–CAF vicious cycle in osteosarcoma. Cell Communication and Signaling In press.
